Stockscreener 앱 받기
10.30
0.59%
0.084
Kura Oncology Inc 주식(KURA)의 최신 뉴스
20 Stocks That Will Double in 2026 - Insider Monkey
EcoR1 Capital LLC Boosts Stock Position in Kura Oncology, Inc. $KURA - MarketBeat
(KURA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Kura Oncology, Inc. $KURA Shares Sold by Armistice Capital LLC - MarketBeat
Kura Oncology, Kyowa Kirin reveal Komsifti combo data for AML - MSN
Insider Sell: Faheem Hasnain Sells 10,000 Shares of Kura Oncology Inc (KURA) - GuruFocus
Insiders Find Solace Selling US$1.4m In Stock With Kura Oncology's Price Down 11% - 富途牛牛
Kura Oncology (NASDAQ:KURA) Shares Down 4.6%What's Next? - MarketBeat
Kura Oncology stock maintains Market Outperform rating at Citizens By Investing.com - Investing.com Canada
Kura Oncology, Inc. (KURA) Fundamental Analysis - Meyka
Kura Oncology (KURA) Reports Promising AML Trial Results - GuruFocus
Kura Oncology, Kyowa Kirin Report 'Encouraging' Drug Combo Data to Treat Acute Myeloid Leukemia - marketscreener.com
Kura Oncology & Kyowa Kirin announce positive Komzifti combination data for acute myeloid - marketscreener.com
Kura Oncology completes first U.S. commercial sale of KOMZIFTI - MSN
Kura Oncology (KURA) Reveals Positive Leukemia Treatment Data - GuruFocus
Kura Oncology and Kyowa Kirin Report Promising Data for KOMZIFTI in Combination Therapy for Acute Myeloid Leukemia at ASH 2025 - Quiver Quantitative
Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML - The Manila Times
Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML - marketscreener.com
Kura Oncology, Inc. $KURA Shares Sold by Walleye Capital LLC - MarketBeat
What analysts say about Kura Oncology Inc stockStock Buy Signals & Free Real-Time Trading Alerts Every Day - earlytimes.in
Price Clustering Detected in Bhaskar Agrochemicals Limited StockVolatility Index Analysis & Reap the Rewards of Patience + Planning - earlytimes.in
Why The Narrative Around Kura Oncology Is Shifting After Komzifti’s FDA Breakthrough - Yahoo Finance
Kura Oncology stock rating reiterated at Market Outperform by Citizens - Investing.com Canada
Franklin Resources Inc. Decreases Stake in Kura Oncology, Inc. $KURA - MarketBeat
FDA approved five NMEs in November - biocentury.com
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - The Malaysian Reserve
Kura Oncology (NASDAQ:KURA) Trading Up 7.3%What's Next? - MarketBeat
Kura Oncology: A Cautious Buy (NASDAQ:KURA) - Seeking Alpha
Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia - The Manila Times
Kura Oncology completes first commercial sale of leukemia drug By Investing.com - Investing.com Canada
Geode Capital Management LLC Purchases 211,470 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology Announces First U.S. Sale of KOMZIFTI - MSN
Kura Oncology (KURA) Is Down 7.2% After First KOMZIFTI Sale Triggers $135M Milestone Payment - simplywall.st
Kura Oncology: Expect Volatility Following Ziftomenib Phase 1b Data (NASDAQ:KURA) - Seeking Alpha
Kura Oncology, Inc. Completes Collaboration and License Agreement with Kyowa Kirin - marketscreener.com
Kura Oncology Expects $135 Million Milestone Payment for First US Sale of Komzifti - marketscreener.com
Kura Oncology announces first US sale of KOMZIFTI, triggering $135 million payment - Investing.com Nigeria
Kura Oncology (KURA) Secures $135 Million Milestone with KOMZIFT - GuruFocus
Kura Oncology announces first US sale of KOMZIFTI, triggering $135 million payment By Investing.com - Investing.com South Africa
Kura Oncology completes first commercial sale of leukemia drug - Investing.com
First U.S. commercial sale of Komzift triggers $135 million milestone payment to Kura Oncology - marketscreener.com
First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin - The Manila Times
Kura Oncology (Nasdaq: KURA) to receive $135M as KOMZIFTI launches in U.S. market - Stock Titan
How Kura Oncology Inc. stock trades during market volatilityRate Hike & Daily Growth Stock Investment Tips - Newser
How geopolitical tensions affect Kura Oncology Inc. stockWeekly Stock Report & Technical Confirmation Trade Alerts - Newser
How rising interest rates impact Kura Oncology Inc. stock - Newser
Is Megatherm Induction Limited Stock a Strong Buy According to Wall StreetLarge Cap Stability Picks & Free Unlock Stock Analysis - earlytimes.in
Rhenman & Partners Asset Management AB Boosts Stake in Kura Oncology, Inc. $KURA - MarketBeat
Magnetar Financial LLC Buys 64,345 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Foresite Capital Management IV LLC Has $4.71 Million Holdings in Kura Oncology, Inc. $KURA - MarketBeat
KOMZIFTI™ (ziftomenib) Added to National Comprehensive Cancer Network® (NCCN) Guidelines for Acute Myeloid Leukemia (AML) - The Manila Times
Kura Oncology’s leukemia drug added to NCCN treatment guidelines By Investing.com - Investing.com Australia
Kura Oncology’s leukemia drug added to NCCN treatment guidelines - Investing.com UK
Kura Oncology stock rises after KOMZIFTI added to NCCN treatment guidelines - Investing.com Canada
0.56%
1.23%
자본화:
|
볼륨(24시간):